Endothelial Dysfunction as a Factor in the Pathogenesis of Chronic Heart Failure of Various Genesis

  • T. I. Salyzhyn Ivano-Frankivsk National Medical University, Ivano-Frankivsk
Keywords: chronic heart failure, chronic kidney disease, hemodialysis, endothelial dysfunction, chronic inflammation


The objective of the research was to study the pathogenetic role of the levels of endothelin-1 (ET-1), tumor necrosis factor-alpha (TNF-alpha) and C-reactive protein (CRP) in the development of endothelial dysfunction (ED) in patients with preserved and lost renal function.

Materials and methods. The study involved 86 patients: Group I included 42 patients with arterial hypertension and chronic heart failure (CHF) IIA FC ІІІ; Group II consisted of 44 patients with terminal chronic kidney disease (stage V CKD) with concomitant CHF IIA FC ІІІ who were on treatment by outpatient program hemodialysis (HD).

Results. In patients of Group II the levels of ET-1 and inflammatory markers were significantly higher than those in the comparison and control groups (p<0.001 and p<0.001). In patients of Group I there was a direct moderate correlation between TNF-alpha and ET-1 (r=0.48; p<0.05) and between CRP and ET-1 (r=0.56; p<0.05). In Group II, the relation between TNF-alpha and ET-1 was significantly stronger (r=0.58; p<0.05); between the levels of CRP and ET-1 it was weaker (r=0.37, p<0.05). Increased levels of ET-1, TNF-± and CRP affected the development of ED in both groups.

Conclusions. It was found that CRP levels of TNF-alpha, ET-1 in patients on HD were significantly different from the same data in patients with preserved renal function, which is clearly associated with more pronounced signs of inflammation and ED in a cohort of dialysis patients. The impact of TNF-± in the development of ED in both groups was proved. Despite the higher level of CRP in patients with stage V CKD being corrected by HD with CHF, this biomarker had less impact on the prognosis of ED than in the general population of patients with CHF.


Beloglazov VA, Klimchuk AV. I antiendotoxic immunity and the level of C-reactive protein in patients with chronic kidney disease who are on dialysis. Tavricheskiy mediko-biologicheskiy vestnik. 2013; 4: 25-28.

Voronkov LH. “Path” of patients with chronic heart failure: as long as possible, as comfortable as possible. Sertseva nedostatnist. 2014; 1: 7-10.

Zaremba YeKh, Besedina AS, Zaremba-Fedchyshyn OV. Determination of endothelin-1 level to assess the correction of endothelial dysfunction in patients with chronic heart failure. Medychna i klinichna khimiia. 2011; 13 (4): 73-74.

Zaremba YeKh, Smaliukh OV. Inflammatory markers and endothelial function in patients with coronary artery disease (literature review). Bukovynskyi medycnhyi visnyk. 2014; 18,4 (72): 192-195.

Zolotariova NA, Romanchenko MI. Endothelial dysfunction: diagnostic significance, methods for determination. Odeskyi medychnyi zhurnal. 2013; 2: 77-84.

Kurapova MV, Nizyamova AR, Romasheva EP, Lavydkin IL. Endothelial dysfunction in patients with chronic kidney disease. Izvestiya Samarskogo nauchnogo tsentra Rossiyskoi akademii nauk. 2013; 3: 1823-1826.

Kuryliv HM. The severity of endothelial dysfunction in patients with chronic heart failure. Aktualni problemy suchasnoi medytsyny: visnyk VDNZU “Ukraiinska meduchna stomatolohichna akademiia”. 2013; 13 (3): 168-172.

Riabenko DV. Pharmacotherapy of chronic heart failure in the nineteenth century. Sertseva nedostatnist. 2014; 2: 24-33.

Sheiko SO. Endothelial dysfunction in elderly patients with chronic heart failure and anemia syndrome symptoms depending on the stage of heart failure and left ventricular ejection fraction. Medychni perspectyvy. 2010; ХV (1): 41-47.

Allon M. Evidence-Based Cardiology in Hemodialysis Patients. Journal of the American Society of Nephrology. 2013; 24: 1934–1943.

Lee MJ, Han SH, Lee JE, et al. Endothelial Dysfunction Is Associated With Major Adverse Cardiovascular Events in Peritoneal Dialysis Patients. Medicine. 2014; 93: 73-82.

Ioannou K, Stel VS, Dounousi E, et al. Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal Study. PLoS one. 2015; 10: 1-9.

Teixeira BC, Lopes AL, Oliveira Macedo RC, et al. Inflammatory markers, endothelial function and cardiovascular risk. Jornal Vascular Brasileiro. 2014; 13: 108-115.

Nessler J, Nessler B, Golebiowska-Wiatrak R, et al. Serum biomarkers and clinical outcomes in heart failure patients treated de novo with carvedilol. Cardiology Journal. 2013; 20: 144-151.

Original Research